Clinical Trial 42061

Fayetteville, NC 28304


Summary:

Help Pneumococcal Vaccine Research

If you’ve been vaccinated against pneumococcal disease, you may be eligible for a clinical study.

Pneumococcus can cause serious diseases.

Right now, a clinical study is testing an investigational vaccine to learn about the safety and immune responses it produces against 20 strains of pneumococcus (Streptococcus pneumoniae), a type of bacteria that can lead to pneumonia, blood infection, and other serious diseases.

If you’re age 65 or older and have already received a pneumococcal vaccine, you may be able take part in our study. By participating, you will receive either an investigational or an approved vaccine, study-related medical care, and reimbursement for travel.

This study is for research purposes only. There may not be a direct benefit to you if you take part, but information learned from the study may help other people in the future.


Qualified Participants Must:

• Be age 65 or older
• Have been vaccinated with a pneumococcal vaccine


Qualified Participants May Receive:

  • Reimbursement for travel
  • An investigational vaccine or an approved vaccine that may help prevent pneumococcal disease
  • Study-related medical care


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.